Yuhuan Gong
CAS Key Laboratory Of Pathogen Microbiology And Immunology
Beijing, 100101, China
Beijing, 100101, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Anti-infection effects of heparin on SARS-CoV-2 in a diabetic mouse model.
Journal: Zoological research
Published: September 27, 2023
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.
Journal: Nature communications
Published: July 27, 2022
Co-existence and co-infection of influenza A viruses and coronaviruses: Public health challenges.
Journal: Innovation (Cambridge (Mass.))
Published: May 19, 2022
Establishment of human distal lung organoids for SARS-CoV-2 infection.
Journal: Cell discovery
Published: May 31, 2021
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibody.
Journal: EMBO molecular medicine
Published: May 12, 2021
Landscapes and dynamic diversifications of B-cell receptor repertoires in COVID-19 patients.
Journal: Human immunology
Published: March 29, 2021
Integrated gut virome and bacteriome dynamics in COVID-19 patients.
Journal: Gut microbes
Published: March 08, 2021
Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity.
Journal: Science China. Life sciences
Published: October 28, 2020
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infection.
Journal: Nature communications
Published: September 10, 2020
Comparative study on virus shedding patterns in nasopharyngeal and fecal specimens of COVID-19 patients.
Journal: Science China. Life sciences
Published: May 24, 2020
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2.
Journal: Science (New York, N.Y.)
Published: April 13, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026